Excerpt
The diagnosis of hepatitis C virus (HCV) infection in children born to HCV-infected women is currently based on the detection of specific (nonmaternal) IgG antibody and/or the detection of HCV RNA by PCR. 1 However, the age at which passively acquired maternal antibody declines to undetectable levels and the sensitivity and specificity of PCR at different ages have not been accurately determined, with two important consequences for clinical management: (1) it is unclear how confidently infection can be excluded or inferred after a negative and positive PCR result, respectively, or when infection can be definitively diagnosed on the basis of a positive antibody test; (2) it hinders consideration of the most effective diagnostic test strategy, i.e., which assays should be performed at different ages. The high cost of PCR tests, the possibility of viral clearance and potential difficulties in maintaining follow-up of infants of indeterminate infection status, are other important factors that should be taken into account in this decision.